Global Blood Therapeutics - 48 Year Dividend History | GBT

Historical dividend payout and yield for Global Blood Therapeutics (GBT) since 1971. The current TTM dividend payout for Global Blood Therapeutics (GBT) as of November 19, 2019 is $0.00. The current dividend yield for Global Blood Therapeutics as of November 19, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $3.081B $0.000B
Global Blood Therapeutics, Inc. is a biopharmaceutical company which is engaged in discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. Its product candidate consists of GBT440 is an oral, once-daily prophylactic therapy for sickle cell disease which is in clinical trial. The company in addition to GBT is involved in research and development activities targeted hypoxemic pulmonary disorders, including idiopathic pulmonary fibrosis and hereditary angioedema. Global Blood Therapeutics, Inc. is based in South San Francisco, California.
Stock Name Country Market Cap PE Ratio